Bruce Walker is the Director of the Ragon Institute of MGH, MIT and
Harvard, a Professor of Medicine at Harvard Medical School, a Professor of
Practice at MIT and a Howard Hughes Medical Institute Investigator. In
addition to his clinical duties as a board certified Infectious Disease
specialist, his research focuses on cellular immune responses in chronic
viral infections, with a particular focus on HIV. He leads an international
translational clinical and basic science research effort to understand how
some rare people who are infected with HIV, but have never been treated,
can fight the virus with their immune system. Dr. Walker is also an Adjunct
Professor at the Nelson Mandela School of Medicine in Durban, South
Africa. There he collaborates with the Doris Duke Medical Research
Institute at the University of KwaZulu-Natal and serves as a Principal
Investigator in the HIV Pathogenesis Program, an initiative to study the
evolution of the HIV and the immune responses effective in controlling this
virus, as well as to contribute to training African scientists.
At the completion of this educational session, learners will:
- Understand the immunologic and host genetic basis for durable control.
- Appreciate the current barriers to long-term functional cure.
- Understand prospects for reactivation and immunologic elimination of the latent virus reservoir.
This CME activity was approved for AMA PRA Category 1 Credit™
on May 23, 2017 and will terminate May 22, 2020.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Walker (Presenter) has no relevant financial relationships to disclose. Dr. Walker will support his presentation and clinical recommendations with the best available evidence from the medical literature, and will submit his slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the PRN Courses Page
at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.